Ran Huo

885 total citations
38 papers, 571 citations indexed

About

Ran Huo is a scholar working on Neurology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Ran Huo has authored 38 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 8 papers in Molecular Biology and 5 papers in Biomedical Engineering. Recurrent topics in Ran Huo's work include Vascular Malformations Diagnosis and Treatment (21 papers), Intracranial Aneurysms: Treatment and Complications (18 papers) and Intracerebral and Subarachnoid Hemorrhage Research (14 papers). Ran Huo is often cited by papers focused on Vascular Malformations Diagnosis and Treatment (21 papers), Intracranial Aneurysms: Treatment and Complications (18 papers) and Intracerebral and Subarachnoid Hemorrhage Research (14 papers). Ran Huo collaborates with scholars based in China, United States and Hong Kong. Ran Huo's co-authors include Yong Cao, Hao Li, Zihan Yan, Yuming Jiao, Jizong Zhao, Weilun Fu, Hongyuan Xu, Jiancong Weng, Jie Wang and Shuo Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Circulation Research.

In The Last Decade

Ran Huo

38 papers receiving 568 citations

Peers

Ran Huo
Weilun Fu China
Guohui Lu China
Eleanna Papa Switzerland
H. Jeffrey Kim United States
Mark W. Youngblood United States
Saman Sizdahkhani United States
Weilun Fu China
Ran Huo
Citations per year, relative to Ran Huo Ran Huo (= 1×) peers Weilun Fu

Countries citing papers authored by Ran Huo

Since Specialization
Citations

This map shows the geographic impact of Ran Huo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Huo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Huo more than expected).

Fields of papers citing papers by Ran Huo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Huo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Huo. The network helps show where Ran Huo may publish in the future.

Co-authorship network of co-authors of Ran Huo

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Huo. A scholar is included among the top collaborators of Ran Huo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Huo. Ran Huo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Qi, Yan Su, Mei Dong, et al.. (2025). NIR-Triggered siRNA Release and Lysosomal Escape for Synergistic Photothermal Tumor Therapy. International Journal of Nanomedicine. Volume 20. 4863–4882. 3 indexed citations
2.
Huo, Ran, et al.. (2025). High-Throughput Single-Molecule Microscopy with Adaptable Spatial Resolution Using Exchangeable Oligonucleotide Labels. ACS Nano. 19(13). 13149–13159. 1 indexed citations
3.
Zhang, Jie, Qi Sun, Yaoqi Wang, et al.. (2025). Cancer cell membrane-camouflaged pH-responsive nanoparticles for enhancing siRNA effect and synergistic anti-tumor therapy. Journal of Nanobiotechnology. 23(1). 471–471. 2 indexed citations
4.
Zhang, Shuang, et al.. (2024). Foam Cell Targeted Liposomes Co-Encapsulating Superoxide Dismutase and Catalase to Attenuate Atherosclerosis by Inhibiting Oxidative Stress. Discovery Medicine. 36(181). 343–343. 1 indexed citations
5.
He, Qiheng, Ran Huo, Hongyuan Xu, et al.. (2024). Cerebral vascular malformations: pathogenesis and therapy. SHILAP Revista de lepidopterología. 5(12). e70027–e70027. 1 indexed citations
6.
He, Qiheng, Ran Huo, Jie Wang, et al.. (2023). Exosomal miR‐3131 derived from endothelial cells with KRAS mutation promotes EndMT by targeting PICK1 in brain arteriovenous malformations. CNS Neuroscience & Therapeutics. 29(5). 1312–1324. 14 indexed citations
7.
Li, Dandan, Danni Liu, Yaoqi Wang, et al.. (2023). Multifunctional liposomes Co-encapsulating epigallocatechin-3-gallate (EGCG) and miRNA for atherosclerosis lesion elimination. Nanoscale Advances. 6(1). 221–232. 7 indexed citations
8.
Huo, Ran, Yingxi Yang, Zongchao Mo, et al.. (2023). Endothelial hyperactivation of mutant MAP3K3 induces cerebral cavernous malformation enhanced by PIK3CA GOF mutation. Angiogenesis. 26(2). 295–312. 13 indexed citations
9.
Xu, Hongyuan, Ran Huo, Hao Li, et al.. (2022). KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway. Stroke and Vascular Neurology. 8(3). 197–206. 18 indexed citations
10.
Jiao, Yuming, Jiancong Weng, Ran Huo, et al.. (2022). Artificial Intelligence–Assisted Evaluation of the Spatial Relationship between Brain Arteriovenous Malformations and the Corticospinal Tract to Predict Postsurgical Motor Defects. American Journal of Neuroradiology. 44(1). 17–25. 6 indexed citations
11.
Huo, Ran, Jie Wang, Jiancong Weng, et al.. (2022). Simplex cerebral cavernous malformations with MAP3K3 mutation have distinct clinical characteristics. Frontiers in Neurology. 13. 946324–946324. 4 indexed citations
12.
Fu, Weilun, Wenjing Wang, Hao Li, et al.. (2021). CyTOF Analysis Reveals a Distinct Immunosuppressive Microenvironment in IDH Mutant Anaplastic Gliomas. Frontiers in Oncology. 10. 560211–560211. 7 indexed citations
13.
Yu, Fei, et al.. (2021). Evaluation of isolated abdominal visceral artery dissection with multi-scale spiral computed tomography: a retrospective case series. Journal of Cardiothoracic Surgery. 16(1). 61–61. 2 indexed citations
14.
Li, Hao, Yoonhee Nam, Ran Huo, et al.. (2021). De Novo Germline and Somatic Variants Convergently Promote Endothelial-to-Mesenchymal Transition in Simplex Brain Arteriovenous Malformation. Circulation Research. 129(9). 825–839. 32 indexed citations
15.
Weng, Jiancong, Yingxi Yang, Song Dong, et al.. (2021). Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation. The American Journal of Human Genetics. 108(5). 942–950. 55 indexed citations
16.
Fu, Weilun, Wenjing Wang, Hao Li, et al.. (2020). Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma. Frontiers in Immunology. 11. 835–835. 122 indexed citations
17.
Xue, Yimeng, Hao Li, Ran Huo, et al.. (2020). Wilms' tumour 1‐associating protein inhibits endothelial cell angiogenesis by m6A‐dependent epigenetic silencing of desmoplakin in brain arteriovenous malformation. Journal of Cellular and Molecular Medicine. 24(9). 4981–4991. 51 indexed citations
18.
Wang, Lin-Jian, Yimeng Xue, Ran Huo, et al.. (2020). N6-methyladenosine methyltransferase METTL3 affects the phenotype of cerebral arteriovenous malformation via modulating Notch signaling pathway. Journal of Biomedical Science. 27(1). 62–62. 41 indexed citations
19.
20.
Wang, Ximing, et al.. (2008). The Value of Three-Dimensional Computed Tomographic Angiography in the Diagnosis and Treatment of Vascular Lesions. Plastic & Reconstructive Surgery. 122(5). 1417–1424. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026